PortViewPortView
Canton Strategic logo

Canton Strategic (CNTN) Stock Analysis

NASDAQHealthcareBiotechnology

$2.21-3.29%
1-year price historyRange $1.85 – $5.48
52-week range$2.21
$1.75$6.89

What Canton Strategic does

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.

Key metrics

Market cap
$170.06M
P/E (TTM)
-0.70
EPS (TTM)
$-3.17
Beta
1.47
Dividend yield
0.00%
Revenue / share
$0.01
50-day avg
$2.25
200-day avg
$3.08
52-week high
$6.89
52-week low
$1.75
CEO
Mark Wendland

ETFs linked to CNTN

Broad-market and Healthcare sector ETFs an investor holding Canton Strategic is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CNTN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CNTN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Canton Strategic?
Canton Strategic trades under the ticker CNTN on NASDAQ.
Which exchange is CNTN listed on?
CNTN is listed on NASDAQ.
What sector does Canton Strategic operate in?
Canton Strategic is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CNTN in a portfolio?
PortView shows CNTN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.